Cdc2 expression in primary thyroid lymphoma: Its relationship with biological aggressiveness and G2 cyclins

Pathology Research and Practice

Volumn 199, Issue 8, 2003, Pages 533-538

  Ito, Yasuhiro ^a   Yoshida, Hiroshi ^a   Matsuzuka, Fumio ^a   Matsuura, Nariaki ^b   Nakamura, Yasushi ^c   Nakamine, Hirokazu ^c   Kakudo, Kennichi ^c   Kuma, Kanji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

cdc2; Immunohistochemistry; Malignant lymphoma; Thyroid

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE 2; KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ONCOLOGICAL PARAMETERS; PROTEIN EXPRESSION; THYROID CANCER;

EID: 0141781134     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00458     Document Type: Article

References (19)

1. Banerjee SK, Weston AP, Zoubine MN, Campbell DR, Cherian R (2000) Expression of cdc2 and cyclin B1 in Helicobacter Pyroli-associated gastric MALT and MALT lymphoma: relationship to cell death, proliferation, and transformation. Am J Pathol 156: 217-225
2. Chao Y, Shih Y-L, Chiu J-H, Chau G-Y, Lui W-Y, Yang W-K, Lee S-D, Huang T-S (1998) Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res 58: 985-990
3. Furihata M, Ishikawa T, Inoue A, Yoshikawa C, Sonobe H, Ohtsuki Y, Araki K, Ogoshi S (1996) Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2: 1781-1785
4. Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N (2000) Expression and prognostic role of cyclin dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 59: 68-74
5. Ito Y, Takeda T, Wakasa K, Tsujimoto M, Okada M, Matsuura N (2002) Expression of the G2-M modulators in pancreatic adenocarcinoma. Pancreatology 2: 138-145
6. Ito Y, Yoshida H, Nakano K, Takamura Y, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A (2002) Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation. Pathol Res Pract 198: 397-402
7. Jin YH, Park CK (2002) Expression of cyclin B1 and cdc2 in nodal non-Hodgkin's lymphoma and its prognostic implications. J Korean Med Sci 17: 322-327
8. Kawamoto H, Koizumi H, Uchikoshi T (1997) Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am J Pathol 150: 15-23
9. Lianos M, Alvarez-Argualles H, Aleman R, Oramas J, diaz-Flores L, Batista N (2001) Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein and p53 expression in follicular and diffuse large B-cell lymphoma. Med Oncol 18: 15-22
10. Matsuzuka F, Miyauchi A, Katayama S, Narabayashi I, Ikeda H, Kuma. K, Sugawara M (1993) Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 3: 93-99
11. Matsuzuka F, Fukata S, Kuma K, Miyauchi A, Kakudo K, Sugawara M (1998) Gene rearrangement of immunoglobulin as a marker of thyroid lymphoma. World J Surg 22: 558-561
12. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S (1999) Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 434: 153-158
13. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G (1992) Cyclin A is required at two points in the human cell cycle. EMBO J 11: 961-971
14. Pagnano KB, Silva MD, Vassallo J, Aranha FJ, Saad ST (2002) Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin's lymphomas. Acta Haematol 107: 29-34
15. Pines J, Hunter T (1989) Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58: 833-846
16. Pines J, Hunter T (1992) Cyclin A and B1 in the human cell cycle. Ciba Found Symp 170: 187-204
17. Schlumberger MJ, Caillou B (2001) Miscellaneous tumors of the thyroid. THYROID Lippincott Williams & Wilkins, 8th ed, pp 944-948
18. Shiozawa T, Xin L, Nikaido T, Fujii S (1997) Immunohistochemical detection of cyclin A with reference of p53 expression in endometrial endometroid carcinomas. Int J Gynecol Pathol 16: 348-353
19. Volm M, Koomagi R, Mattern J, Stammler G (1997) Cylin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 75: 1774-1778